Stephan W. Morris

Fusion (United States) — United States

Medicine · Health Sciences

57h-index16.3kcitations169works3.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(54), Lung Cancer Treatments and Mutations(26), Chronic Lymphocytic Leukemia Research(25), Immune Cell Function and Interaction(15), Cancer-related Molecular Pathways(14)

Publications169 total

Complete remission of <i>NUP98</i> fusion-positive acute myeloid leukemia with the covalent menin inhibitor BMF-219, icovamenib
Haematologica·2024· 6 citedOpen Access
Covalent-103: A phase 1, open-label, dose-escalation and expansion study of BMF-500, an oral covalent FLT3 inhibitor, in adults with acute leukemia (AL).
Journal of Clinical Oncology·2024· 3 cited
Abstract 5147: Identification of pharmacodynamic biomarkers in PBMCs and cancer cells for SIK2 kinase inhibitor therapy
Cancer Research·2024
Covalent Menin Inhibitor Bmf-219 in Patients with Relapsed or Refractory (R/R) Acute Leukemia (AL): Preliminary Phase 1 Data from the Covalent-101 Study
Blood·2023· 26 cited
Covalent-103: A Phase 1, Open-Label, Dose-Escalation, and Dose-Expansion Study of Bmf-500, an Oral Covalent FLT3 Inhibitor, in Adults with Acute Leukemia (AL)
Blood·2023· 1 cited
Supplementary Figure 4 from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
2023Open Access
Supplementary Figure 3 from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
2023Open Access
Supplementary Figure 1 from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
2023Open Access
Supplementary Figure 2 from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
2023Open Access
Supplementary Figure 1 from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
2023Open Access
Supplementary Figure 4 from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
2023Open Access
Supplementary Methods and Figure Legends from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
2023Open Access
Supplementary Figure 3 from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
2023Open Access
Supplementary Methods and Figure Legends from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
2023Open Access
Supplementary Figure 2 from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
2023Open Access
Data from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
2023Open Access
Data from Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
2023Open Access
CARD19, a Novel Regulator of the TAK1/NF-κB Pathway in Self-Reactive B Cells
The Journal of Immunology·2023· 1 citedOpen Access
Relieving DYRK1A repression of MKL1 confers an adult-like phenotype to human infantile megakaryocytes
Journal of Clinical Investigation·2022· 11 citedOpen Access
Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice
Journal of Clinical Oncology·2022· 39 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Liquan Xue(11), Zhigui Ma(10), Laurence Lamant(5), Georges Delsol(5), David Y. Mason(5), Xiaoli Cui(5), Karen Pulford(5), Thomas R. Webb(4), Yi Sun(4), Ren-Yuan Bai(4), Justus Duyster(4), Mark N. Kirstein(3), David N. Shapiro(3), A. Thomas Look(3), D. Ashley Hill(3), Dennis D. Weisenburger(3), Virginia Valentine(3), Christian Peschel(3), Xiaoli Cui(3), Johann Hitzler(3)